Online brain health course could slash dementia risk

NCT ID NCT07364019

Recruiting now Prevention Sponsor: University of British Columbia Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests an online educational program called Brain Health PRO in 700 Canadians at risk for dementia. Participants are randomly assigned to start the 6-month program immediately or after a 6-month delay. The program covers lifestyle factors like diet, exercise, sleep, and social engagement. The goal is to see if the program helps people make lasting changes that could lower their dementia risk.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Brain Health PRO online educational program
What this could lead to: If successful, this could show that an online program helps people make lifestyle changes that lower their risk of dementia.
What could go wrong: This is an early-stage study with no direct treatment. It only measures changes in risk factors, not whether dementia is actually prevented. Results may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COGNITIVE CHANGE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cognitive disorder Cognitive Dysfunction subjective cognitive decline dementia prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COGNITIVE CHANGE DEMENTIA EDUCATION DEMENTIA PREVENTION LIFESTYLE INTERVENTION MILD COGNITIVE IMPAIRMENT SUBJECTIVE COGNITIVE IMPAIRMENT

Contacts and locations

Locations

University of British Colubmia
RECRUITING

Vancouver, British Columbia, V6T 1Z3, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.